Mario SUBRAMANIAM

Mario Subramaniam is a partner in Bird & Bird's highly rated (Legal500 and Chambers) Life Sciences and IP Team, advising Life Science clients on strategic licensing, collaboration and partnering transactions.

He has over 15 years of experience in advising Life Science clients on the development and exploitation of pharmaceutical, biotech, medtech and digital health technologies, with a particular emphasis on strategic IP licensing, collaboration, and partnering transactions, as well as joint ventures, high value manufacturing, supply and outsourcing arrangements. He also provides strategic support on M&A and asset acquisitions and disposals for Life Science clients.

His background includes substantial periods as a research scientist in immunology and molecular biology and as in-house counsel at several prominent Life Science companies. This gives him a unique perspective and a deep understanding of the technology and issues involved in complex and innovative transactions.

He provides clear and pragmatic advice that aligns with clients' business objectives and regulatory strategies. He has been recognized as a notable practitioner and a key lawyer in Life Sciences by IP Stars and Legal 500, respectively. He has contributed to the UK Government's efforts to combat the COVID-19 pandemic by advising on the purchase and deployment of COVID-19 vaccines and antiviral therapies.

”Mario's strong support for commercial goals throughout the negotiations. He provided rapid turnarounds of drafts and was readily available for meetings during a busy period. He brought the deal to a successful conclusion by deadline.”

His Admissions

2009, Admitted to practise in England and Wales
2006, Admitted to practise in Victoria and Federal Court of Australia